Precigen Is A Biopharmaceutical Company Dedicated To Discovering And Developing Next Generation Gene And Cell Therapiesfounded In 1998 And Headquartered In Germantownmarylandprecigen Operates In The Us And Belgiumthe Company Focuses On Addressing Urgent Diseases In Immuno Oncologyautoimmune Disordersand Infectious Diseases Through Precision Technology Precigen Utilizes Various Innovative Platformsincluding Ultracar T For Car T Cell Therapiesadenoverse For Adenovirus Based Therapiesand Actobiotics For Live Biotherapeutic Productstheir Clinical Pipeline Features Products Targeting Conditions Such As Type 1 Diabetesovarian Cancerand Acute Myeloid Leukemiaamong Othersthe Company Is Committed To Developing Affordable Biotherapeutics To Effectively Tackle Critical Health Challenges
No conferences found for this company.
| Company Name | Intrexon Corporation |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
